Neurointerventional Devices Market to be worth US$ 3.6 Billion by the year 2030 - Comprehensive Research Report by FMI

Surging Aneurysm Cases to Drive Neurointerventional Devices Market Growth


DUBAI, United Arab Emirates, March 24, 2022 (GLOBE NEWSWIRE) -- A new report by Future Market Insights (FMI) expects global Neurointerventional Devices Market to grow at 4.7% CAGR through 2030. According to the study, the market will reach US$ 3.6 Bn in revenues by the end of 2030.

Data PointsMarket Insights
Market Value 2021US$ 2.4 Bn
Market Value 2022US$ 2.5 Bn
Market Value 2030US$ 3.6 Bn
CAGR 2022-20304.7%
Market Share of Top 5 Countries72.5%
Key Market PlayersStryker Corporation, Penumbra Inc., Covidien Public Limited,
Johnson & Johnson Private Limited and Terumo Corporation

Request a Report Sample to Gain Comprehensive Insights at
https://www.futuremarketinsights.com/reports/sample/rep-gb-871

Since the past several years, the burden of neurological disorders has increased multifold. According to the National Center for Biotechnology Information (NCBI), the frequency of cerebral aneurysm is nearly 3.2%, with the prevalence being higher amongst women than men above 50 years of age.

It is estimated that around 6.5 million people in the United States possess an unruptured brain aneurysm, while 30,000 suffer a brain aneurysm rupture every year. Based on these trends, it is unsurprising to observe the market being interspersed with the presence of several reputed manufacturers who constantly launch new products.

In addition, rising prevalence of ischemic stroke is also boosting the neurointerventional devices market. Being non-invasive in nature, these devices increase chances of survival during surgery, further fueling market growth. By 2030, a valuation of US$ 3.6 Bn is predicted for the market.

Global Neurointerventional Devices Market- Key Takeaways

  • North America shall be the market hegemon, holding a 40.7% market share from 2020-2030

  • Embolic coils to capture the majority share, carotid stents to surge in popularity

  • High incidence of cerebral aneurysm to accelerate adoption of coiling procedures

  • Presence of experienced surgeons shall accelerate hospital-grade neurointerventional device adoption

For any Queries Related with the Report, Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-871

Scope of the Report

AttributeDetails
Forecast Period2022-2030
Historical Data Available for2013-2021
Market AnalysisUS$ Mn for Value
Key Regions CoveredNorth America, Latin America, Western Europe, Eastern Europe,
Japan, APEJ and Middle East and Africa
Key Countries CoveredU.S., Canada, Brazil, Mexico, Germany, France, U.K., Italy, Spain, Nordic,
BENELUX, Russia, Poland, Japan, China, India, ASEAN, ANZ, Rest of Asia Pacific,
GCC Countries, North Africa and South Africa
Key Market Segments CoveredProduct, Technique, End User and Region
Key Companies Profiled• Stryker Corporation

• Penumbra Inc.

• Covidien Public Limited

• Johnson & Johnson Private Limited

• Terumo Corporation
PricingAvailable upon Request

COVID-19’s Impact on the Market
With respect to neurological disorders, several hospitals and clinics have reported complications in severely or critically ill patients with co-morbidities. COVID-19 has the potential to affect the central and peripheral nervous systems. The virus invades the brain either through the olfactory system or a hematogenous route. Once inside, the virus may cause hypoxic and metabolic abnormalities.

In this light, the neurointerventional devices market is poised to remain afloat in the near-term forecast period. Significant increases in mechanical thrombectomies were reported since April 2020, with majority of the patients seeking treatment for acute strokes from large vessel occlusions (LVOs).

A series of case studies on over 200 COVID-19 positive patients in Wuhan, China, 36.4% of patients exhibited neurologic symptoms such as acute cerebrovascular events, muscle injury and impaired consciousness. In this context, the market is poised to experience an adrenaline rush in the short-run.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-871

Competitive Intelligence
Some influential vendors within the landscape include: Stryker Corporation, Covidien Public Ltd., Penumbra Inc., Terumo Corporation, Johnson & Johnson Private Limited, Medtronic PLC, Boston Scientific Corporation and Abbott.

Players are emphasizing on expanding their businesses through partnerships, collaborations and mergers & acquisitions and participation in trade fairs. Many of them are also aligning with research institutes to augment their research capacities.

In August 2020, Stryker Corporation successfully launched its Surpass Evolve flow diverter after receiving FDA clearance in the U.S market. The device has already been in use in Europe since 2019.

In September 2020, Penumbra Inc. shall participate in the virtual Global Embolization Symposium & Technologies 2020 Conference. The company hopes to broaden its outreach and collaborate with other leading players to develop and launch new neurointerventional devices, thus expanding its existing product portfolio.

Explore FMI’s Extensive ongoing Coverage on Packaging Domain 

Pathology Devices Market - Pathology is the field in healthcare which provides accurate information regarding the progression of disease conditions. This information helps physicians to monitor and manage the therapies.

Artificial Pancreas Device System Market - During the forecast period, the artificial pancreas device system market is expected to advance at a rapid pace with a CAGR of 18.2%.

Vertebroplasty and Kyphoplasty Devices Market - The vertebroplasty and kyphoplasty devices market is expected to record a CAGR of 4.4% during the forecast period.

Compliance Monitoring Devices Market - The rising prevalence of chronic diseases and improvements in diagnosis methodologies are also projected to contribute to the growth of the compliance monitoring devices market share.

Nerve Monitoring Devices Market - The nerve monitoring devices market is likely to record a CAGR of 6.1% during the forecast period, up from US$ 1.1 Bn in 2021 to reach a valuation of US$ 1.7 Bn by 2026.

Minimally Invasive Neurosurgery Devices Market - Studies reveal that over 17 million surgical operations happen every year. While surgeries have been life-saving, lengthy recovery time after surgeries have been an ongoing concern in the healthcare industry.

Respiratory Measurement Devices Market - The respiratory measurement devices market is anticipated to record a CAGR of 7.2% during the forecast period 2022-2032.

Refractive Surgery Devices Market - The refractive surgery devices market is anticipated to register a CAGR of 9.6 % during the forecast period, up from US$ 175.08 Bn in 2020 to reach a valuation of US$ 332.6 Bn by 2027.

Nephrology and Urology Incontinence Devices Market - The nephrology and urology incontinence devices market is expected to record a CAGR of 4.1% during the forecast period, up from US$ 38 Bn in 2021 to reach a valuation of US$ 46.4 Bn by 2026.

Dose Monitoring Devices Market - The dose monitoring devices market is likely to record a CAGR of 5.2% during the forecast period, up from US$ 2.8 Bn in 2020 to reach a valuation of US$ 4 Bn by 2026.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centres in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:

Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/neurointerventional-devices-market